Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ATNAHS PHARMA US

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 38
  • 0 comments

FDA approve NAPROXEN

Comment Full text

QILU

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 50
  • 0 comments

FDA approve ICOSAPENT ETHYL

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 47
  • 0 comments

FDA approve ASPIRIN; MEPROBAMATE

Comment Full text

ZYLA LIFE SCIENCES

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 53
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

AVION PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 45
  • 0 comments

FDA approve MEFENAMIC ACID

Comment Full text

KEY THERAP

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 49
  • 0 comments

FDA approve FENOPROFEN CALCIUM

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 42
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 43
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

ZYLA LIFE SCIENCES

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 45
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

HIKMA

  • FDA Approval
  • Nov. 21, 2024, 09:48 UTC
  • 49
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text
  • Previous
  • 309
  • 310
  • 311
  • 312
  • 313
  • Next

Search

News categories

  • Technical Exchange News(11495)
  • Event(3373)
  • SEC News(216291)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137404)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin